We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study.
- Authors
Swerdlow, A J; Higgins, C D; Adlard, P; Preece, M A
- Abstract
Growth hormone raises serum concentrations of insulin-like growth factor IGF-I, which is mitogenic and antiapoptotic. There is evidence that raised endogenous levels of growth hormone and IGF-I might be associated with increased risk of certain solid cancers, but there have been no data on long-term risks of solid cancers after growth hormone treatment.
- Publication
Lancet (London, England), 2002, Vol 360, Issue 9329, p273
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(02)09519-3